Page 5 - ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் Today - Breaking & Trending Today

C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B – TechCrunch


C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B
If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so, will the doctors catch it at an early enough stage? C2i Genomics has developed software that’s 100x more sensitive in detecting residual disease, and investors are pouncing on the potential. Today, C2i announced a $100 million Series B led by Casdin Capital. 
“The biggest question in cancer treatment is, ‘Is it working?’ Some patients are getting treatment they don’t benefit from and they are suffering the side effects while other patients are not getting the treatment they need,” said Asaf Zviran, co-founder and CEO of C2i Genomics in an interview. ....

New York , United States , Asaf Zviran , Idan Landau , Langone Health , York Genome Center , Aarhus University Hospital , National Cancer Center , Lausanne University Hospital , Israeli Defense , Duquesne Family Office , New York Genome Center , Weill Cornell Medicine , Lausanne University , Israeli Defense Force , Globe Partners , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , டான் ல்யாந்‌டா , லன்கொனே ஆரோக்கியம் , யார்க் மரபணு மையம் , ஆர்ஹஸ் பல்கலைக்கழகம் மருத்துவமனை , தேசிய புற்றுநோய் மையம் , இஸ்ரேலி பாதுகாப்பு , ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் , புதியது யார்க் மரபணு மையம் ,

C2i Genomics Raises $100M in Funding


C2i Genomics, a New York, NY-based cancer intelligence company, raised $100m in financing.
The round was led by Casdin Capital with participation from NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others. The financing was executed as a convertible note with two tranches of $50m, called by the company with additional participation from The Mark Foundation for Cancer Research, Silver Lake, Alexandria Real Estate, Gordon Asset Management, and LionBird. 
The company intends to use the funds to accelerate clinical development and commercialization of its C2-Intelligence Platform and to deepen its partnerships with pharmaceutical companies.
Led by Asaf Zviran, co-founder and CEO, C2i provides a cloud-based cancer diagnostics service that uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease. ....

Silver Lake , New York , United States , United Kingdom , Al Iskandariyah , Asaf Zviran , Langone Health , Aarhus University Hospital , Mark Foundation For Cancer Research , National Cancer Center , Lausanne University Hospital , Duquesne Family Office , Casdin Capital , Globe Partners , Driehaus Capital , Mark Foundation , Cancer Research , Alexandria Real Estate , Gordon Asset Management , Intelligence Platform , வெள்ளி ஏரி , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , லன்கொனே ஆரோக்கியம் , ஆர்ஹஸ் பல்கலைக்கழகம் மருத்துவமனை ,

Billionaire investors Bill Ackman and Stanley Druckenmiller invested in Coupang years before its $4.6 billion IPO this week


Billionaire investors Bill Ackman and Stanley Druckenmiller invested in Coupang years before its $4.6 billion IPO this week
tmohamed@businessinsider.com (Theron Mohamed)
Bill Ackman and Stanley Druckenmiller were early investors in South Korea s Coupang.
Ackman introduced founder Bom Kim to another of his key investors, David Frankel.
Rose Park Advisors, founded by author Clayton Christensen, is another shareholder.
Billionaire investors Bill Ackman and Stanley Druckenmiller were early backers of Coupang, the South Korean e-commerce group which raised $4.6 billion on Thursday in the biggest US IPO of the year so far.
David Frankel, the cofounder of Founder Collective, tweeted a slide from one of Coupang s investor presentations that listed his firm and Ackman as key investors. It also named Rose Park Advisors, the investment firm set up by Clayton Christensen - the late Harvard Business School professor and author of The Innovator s Dile ....

South Korea , South Korean , Allen Fredrickson , Kevin Warsh , David Frankel , Bill Ackman , Matthew Christensen , Clayton Christensen , Stanley Druckenmiller , Harvard Business School , Softbank Vision Fund , Druckenmiller Duquesne Family Office , Allen Fredrickson Bill , Bom Kim , Park Advisors , Founder Collective , Rose Park Advisors , Business School , Pershing Square Capital Management , Duquesne Family Office , Rose Park , தெற்கு கொரியா , தெற்கு கொரியன் , ஆலன் ப்ரெதிரிகக்சோன் , டேவிட் பிராங்கல் , ர சி து அக்கமன் ,